==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 108
IDThPPIDNamePeptide SequenceLengthFunctional ClassificationDiseaseBrandCompanyPhysical AppearanceRoute of AdministartionCategoryTarget
1844Th1232LenograstimNA Full view0IbImmunological DisordersGranocyteNASolidSubcutaneous or IntravenousAntineoplastic and Immunomodulating Agents Granulocyte colony-stimulating factor receptor
1845Th1233PegloticaseTYKKNDEVEFVRTGYGKDMI Full view298IbOsteological DisordersPegloticase (Krystexxa)NASolidIntravenousEnzymes Uric acid
1846Th1234Protamine sulfateNA Full view0IbHematological DisordersProtamine Sulfate Injection, USPOmega Laboratories Ltdoff-white amorphous or crystalline powderIntravenousHeparin Antagonists, Hematologic Agents NA
1847Th1235Protein S humanANSLLEETKQGNLERECIEE Full view635IbMetabolic DisordersProtein S humanNA SolidNAAnticoagulant plasma protein NA
1849Th1237Somatropin recombinantFPTIPLSRLFDNAMLRAHRL Full view191IbHormonal DisordersBioTropinBiotech GeneralPowder and Solvent for SolutionSubcutaneousHormones, Hormone Substitutes, and Hormone Antagonists Growth hormone receptor, Prolactin receptor
1850Th1237Somatropin recombinantFPTIPLSRLFDNAMLRAHRL Full view191IbHormonal DisordersNutropinAQGenentech Inc.Sterile liquidSubcutaneousHormones, Hormone Substitutes, and Hormone Antagonists Growth hormone receptor, Prolactin receptor
1851Th1238Susoctocog alfaAIRRYYLGAVELSWDYRQSE Full view1448IbHematological DisordersObizurNAPowder and solvent for solution for injection.IntravenousBlood coagulation factors, Antihaemorrhagics von Willebrand factor
1852Th1239Thrombomodulin AlfaNA Full view0IbHematological DisordersRecomodulin (in Japan only)Asahi Kasei Pharma Corplyophilized powder for solutionIntravenous Anticoagulant agent, Antiplatelet agent Prothrombin, Coagulation factor V